Related Experiment Videos
Recombinant endothelial nitric oxide synthase: post-translational modifications in a baculovirus expression system
1Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School Boston, Massachusetts 02115, USA.
Molecular Pharmacology
|April 1, 1995
Summary
Researchers purified and characterized endothelial nitric oxide synthase (ecNOS) using a recombinant baculovirus system. This method yields stable, functional ecNOS, aiding further structural and enzymological studies.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Endothelial nitric oxide synthase (ecNOS) regulates blood pressure and platelet aggregation.
- ecNOS is a membrane-associated protein challenging to isolate and characterize.
- Post-translational modifications (myristoylation, palmitoylation, phosphorylation) affect ecNOS function.
Purpose of the Study:
- To develop a method for purifying and characterizing ecNOS.
- To investigate the fidelity of ecNOS biosynthesis and modification in a heterologous system.
Main Methods:
- Expression of recombinant ecNOS in Sf9 insect cells using a baculovirus vector.
- Purification of recombinant ecNOS via a single-step procedure.
- Biosynthetic labeling and immunoprecipitation to analyze post-translational modifications.
Main Results:
- Recombinant ecNOS was successfully expressed and targeted to the Sf9 cell membrane.
- Purified recombinant ecNOS represented approximately 10% of total cellular protein.
- Recombinant ecNOS exhibited myristoylation, palmitoylation, and phosphorylation, mirroring native ecNOS.
Conclusions:
- Recombinant expression in Sf9 cells provides a reliable system for obtaining functional ecNOS.
- This approach facilitates structural and enzymological studies of ecNOS.
- The fidelity of post-translational modifications ensures the relevance of findings from recombinant ecNOS.